The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2026 | Applications of AI to improve surgical outcomes for patients with lung cancer
Kelvin Lau, BA, MA, MBBS, PhD, FRCS, Barts Health NHS Trust, London, UK, shares insights into how artificial intelligence (AI) could be integrated into surgical practice for lung cancer. AI could be used to create better models for predicting whether to operate and identifying which patients will have complications to intervene early. Dr Lau also highlights a use for AI in identification of patients with pathologic complete response after neoadjuvant chemoimmunotherapy who therefore may not require surgery. In addition, AI can be used to predict which patients may experience complications following surgery, allowing for resources to be focused on those affected and early intervention. This interview took place at the IASLC 2026 World Conference on Lung Cancer congress in Seoul, Republic of Korea.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
